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General. All reactions were carried out under Ar in pre-dried glassware using Schlenk 
techniques. The solvents were dried by distillation over the drying agents indicated and were 
stored and transferred under Ar: CH2Cl2 (P4O10), toluene (Na/K), Et2O, THF 
(magnesium/anthracene), MeOH and EtOH (Mg), HMPA (CaH2), pyridine and Et3N (KOH). 
Flash chromatography: Merck silica gel (230-400 mesh). Mp: Gallenkamp apparatus 
(uncorrected). NMR: Spectra were recorded on a Bruker DPX 300, AMX 400 or DMX 600 
spectrometer in the solvent indicated. Chemical shifts (δ) are given in ppm relative to TMS, 
coupling constants (J) in Hz. IR: Nicolet FT-7199, wavenumbers in cm-1. MS: Finnigan MAT 
8200 (70 eV) or Finnigan MAT SSQ 7000 (70 eV). HRMS: MAT 95 (70 eV). Elemental 
analyses: Dornis & Kolbe, Mülheim. Commercially available reagents (Aldrich, Fluka, 
Lancaster) were used as received. 
 
Starting Materials. 5-Hydroxy-2,2-dimethyl-benzo[1,3]dioxin-4-one (4),6   trifluoro-
methanesulfonic acid 2,2-dimethyl-4-oxo-4H-benzo[1,3]dioxin-5-yl ester (5),7a 5-allyl-2,2-
dimethyl-benzo[1,3]dioxin-4-one (6),9 and (4S, 5R)-4-methyl-5-phenyl-3-propionyl-
oxazolidin-2-one (8)32 were prepared according to the literature cited.  
                                                 
32
 Toyota, M.; Hirota, M.; Nishikawa, Y.; Fukumoto, K.; Ihara, M. J. Org. Chem. 1998, 63, 5895. 
 S-2
2-Allyl-6-hydroxy-benzoic acid (7).  A solution of BCl3 (1 M in CH2Cl2, 30 mL, 30 mmol) 
is slowly added to a solution of compound 6 (1.00 g, 4.54 mmol) in CH2Cl2 (80 mL) at 0 °C 
and the resulting mixture is stirred for 5 h at ambient temperature. The organic phase is 
diluted with ethyl acetate (50 mL), washed with brine and dried over Na2SO4. Evaporation of 
the solvent and flash chromatography (hexanes/ethyl acetate/acetic acid, 10:1:1) affords acid 
7 as colourless crystals (0.78 g, 96 %). mp = 98-99°C. 1H-NMR (CDCl3, 300 MHz) δ 11.15 - 
10.75 (1H, br s), 7.38 (1H, dd, J = 8.2, 7.7 Hz), 6.90 (1H, dd, J = 8.2, 0.9 Hz), 6.79 (1H, dd, J 
= 7.7, 0.9 Hz), 6.02 (1H, ddt, J = 17.0, 10.2, 6.3 Hz), 5.07 - 4.96 (2H, m) 3.76 (2H, d, J = 6.3 
Hz); 13C-NMR (CDCl3, 75.5 MHz) δ 175.2, 163.6, 144.3, 137.3, 135.6, 122.7, 116.5, 115.7, 
110.6, 40.1; IR (KBr) 3047, 2853, 2704, 2589, 1643, 1606, 1576, 1441, 1410, 1309, 1293, 
1275, 1237, 1193, 1169, 1124, 1068, 1014, 1002, 915, 814, 792, 757, 707, 573 cm-1; MS (EI) 
m/z (rel. intensity) 178 ([M+], 33), 160 (100), 132 (24), 115 (3), 104 (26), 77 (12), 63 (4), 51 
(11); HR-MS (EI) (C10H10O3) calcd. 178.0630, found 178.0632; C10H10O3 (178.20) calcd. 
C 67.41, H 5.66; found C 67.53, H 5.75. 
  
(4S, 5R)-3-((2R)-2,5-Dimethyl-hex-4-enoyl)-4-methyl-5-phenyl-oxazolidin-2-one (9). A 
solution of substrate 8 (6.64 g, 28.5 mmol) in THF (20 mL) is slowly added to a solution of 
LiHMDS (5.24 g, 31.3 mmol) in THF (150 mL) at −78 °C. Stirring is continued at that 
temperature for 30 minutes prior to the addition of 3,3-dimethylallyl bromide (11.6 mL, 100.6 
mmol) at −5 °C. The mixture is kept at 0 °C for 16 h before the reaction is quenched by 
addition of aq. sat. NH4Cl. Extraction with Et2O, drying of the combined organic phases over 
Na2SO4, evaporation of the solvent and flash chromatography (hexanes/ethyl acetate, 15:1) 
affords product 9 as a colourless oil (7.27 g, 85 %). 1H-NMR (CD2Cl2, 300 MHz) δ 7.47 - 
7.30 (5H, m), 5.65 (1H, d, J = 7.4 Hz), 5.19 - 5.11 (1H, m), 4.77 (1H, dq, J = 7.4, 6.6 Hz), 
3.79 (1H, dq, J = 6.8, 6.8 Hz), 2.45 -2.33 (1H, m), 2.23 -2.11 (1H, m), 1.68 (3H, s), 1.62 (3H, 
s), 1.15 (3H, d, J = 6.8 Hz), 0.83 (3H, d, 6.6 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) δ 176.9, 
153.1, 134.2, 134.1, 129.0, 128.9, 126.1, 121.5, 79.0, 55.0, 38.2, 32.7, 25.8, 17.9, 16.6, 14.7; 
[α]20D = −33.6 (1.32, CH2Cl2); IR (neat) 3065, 3034, 2973, 2933, 2877, 1782, 1700, 1607, 
1497, 1456, 1383, 1368, 1344, 1305, 1241, 1231, 1287, 1198, 1146, 1122, 1090, 1068, 1027, 
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987, 959, 767, 725, 700 cm-1; MS (EI) m/z (rel. intensity) 301 ([M+], 27), 286 (2), 257 (2) 
233 (99), 214 (2), 178 (17), 159 (26), 134 (30), 124 (11), 118 (37), 109 (14), 96 (100), 81 
(26), 69 (21), 55 (29), 41 (29); HR-MS (EI) (C18H23NO3) calcd. 301.1678, found 301.1679; 
C18H23NO3 (301.39) calcd. C 71.73, H 7.69, N 4.65; found C 71.63, H 7.78, N 4.61. 
 
(2R)-2,5-Dimethyl-hex-4-enoic acid (10). Aqueous H2O2 (30 % w/w, 24.1 mL) and a 
suspension of LiOH·H2O (4.43 g, 105.5 mmol) in water (20 mL) are added at 0 °C to a 
solution of compound 9 (15.78 g, 52.4 mmol) in THF (150 mL) and water (50 mL). The 
reaction is quenched after 4 h by addition of a solution of Na2SO3 (30.3 g, 240 mmol) in 
water (100 mL). After stirring for additional 45 minutes, the organic solvent is evaporated and 
the remaining aqueous phase is washed with CH2Cl2. Acidification of the aqueous phase with 
diluted HCl to pH 1, extraction with Et2O, drying of the combined organic phases over 
Na2SO4 and evaporation of the solvent affords product 10 as a colourless oil (7.40 g, 99 %). 
1H-NMR (CDCl3, 300 MHz) δ 10.50 - 10.00 (1H, br s), 5.12 - 5.04 (1H, m), 2.52 - 2.28 (2H, 
m), 2.19 - 2.08 (1H, m), 1.67 (3H, s), 1.59 (3H, s), 1.14 (3H, d, J = 6.9 Hz); 13C-NMR 
(CDCl3, 75.5 MHz) δ 183.0, 134.0, 120.9, 39.8, 31.8, 25.8, 17.8, 16.3; [α]20D = −8.8 (2.08, 
CH2Cl2); IR (KBr) 2975, 2935, 2661, 1710, 1463, 1417, 1378, 1338, 1287, 1245, 1226, 1185, 
1125, 1083, 1049, 933, 856, 812, 778, 625 cm-1; MS (EI) m/z (rel. intensity) 142 ([M+], 24), 
124 (2), 109 (1), 97 (3), 87 (5), 81 (5), 74 (17), 69 (100), 55 (10), 41 (55); HR-MS (EI) 
(C8H14O2) calcd. 142.0994, found 142.0993. 
 
(2R)-2,5-Dimethyl-hex-4-enoyl chloride (11). Chloroenamine 12 (3.50 g, 26.3 mmol) is 
slowly added via syringe to a solution of acid 10 (3.11 g, 21.90 mmol) in CH2Cl2 (40 mL). 
After stirring for 90 minutes the solvent is evaporated in vacuo affording acid chloride 11 as a 
colourless oil. The crude product is dissolved in THF (35 mL) and directly used in the next 
step. 
 
(4R)-4,7-Dimethyl-3-oxo-oct-6-enoic acid methyl ester (13).  A solution of n-BuLi (1.6 M 
in hexane, 53.0 mL, 84.3 mmol) is added at −78 °C to a solution of diisopropylamine (10.75 
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ml, 76.7 mmol) in THF (200 mL). The reaction mixture is stirred for 30 minutes at −20 °C 
prior to the slow addition of methyl acetate (6.10 ml, 76.7 mmol) at −78 °C. After stirring for 
1 h, a solution of acid chloride 11 (21.90 mmol, crude) in THF (35 mL) is added and the 
reaction mixture is quickly warmed to ambient temperature. After 2 h the reaction is quenched 
by addition of aq. sat. NH4Cl. Extraction with Et2O, drying of the combined organic phases 
over Na2SO4, evaporation of the solvent and flash chromatography (hexanes/ethyl acetate, 
15:1) affords keto ester 13 as a colourless oil (3.50 g, 81 %). According to NMR, the product 
consists of a 9:1 mixture of keto-enol tautomers. NMR-Data for major keto-form: 1H-NMR 
(CD2Cl2, 300 MHz) δ 5.09 - 5.02 (1H, m), 3.69 (3H, s), 3.47 (2H, s), 2.69 - 2.58 (1H, m), 
2.36 - 2.24 (1H, m), 2.14 - 2.02 (1H, m), 1.69 (3H, s), 1.61 (3H, s), 1.07 (3H, d, J = 7.0 Hz); 
13C-NMR (CD2Cl2, 75.5 MHz) δ 206.6, 168.1, 134.4, 121.2, 52.4, 48.1, 47.2, 31.5, 25.8, 
17.9, 15.8; [α]20D = −35.1 (1.54, CH2Cl2); IR (KBr) 2971, 2934, 1752, 1715, 1653, 1626, 
1450, 1438, 1405, 1377, 1318, 1237, 1195, 1155, 1119, 1039, 1006, 849, 842, 805, 778, 739, 
703, 658 cm-1; MS (EI) m/z (rel. intensity) 198 ([M+], 18), 180 (8), 166 (4), 143 (13), 130 
(54), 125 (31), 109 (20), 101 (29), 96 (25), 81 (14), 74 (15), 69 (100), 55 (38), 41 (56); HR-
MS (EI) (C11H18O3) calcd. 198.1256, found 198.1254; C11H18O3 (198.26) calcd. C 66.64, H 
9.15; found C 66.52, H 9.08. 
 
(3S,4R)-3-Hydroxy-4,7-dimethyl-oct-6-enoic acid methyl ester (14). A stainless steel 
autoclave (50 mL) is charged with a solution of compound 13 (594 mg, 3 mmol) in MeOH 
(20 mL). After addition of [(R)-BINAP·RuCl2]2·NEt3 (3.1 mM in THF, 8 mL, 0.025 mmol, 
0.8 mol %) the autoclave is pressurized with H2 (4 atm) and the reaction mixture is stirred for 
4 h at 80 °C. After venting the autoclave, the solvent is removed in vacuo and the residue is 
purified by flash chromatography (hexanes/ethyl acetate, 6:1) affording product 14 (575 mg, 
96 %) as a colourless oil. 1H-NMR (CD2Cl2, 300 MHz) δ 5.14 (1H, ddsept, J = 7.8, 6.8, 1.4 
Hz), 3.83 (1H, dddd, J = 9.5, 6.1, 4.0, 2.6 Hz), 3.68 (3H, s), 2.82 (1H, d, J = 4.0 Hz), 2.50 
(1H, dd, J = 16.1, 2.9 Hz), 2.38 (1H, dd, J = 16.1, 9.6 Hz), 2.15 (1H, ddd, J = 14.2, 6.8, 4.8 
Hz), 1.89 (1H, ddd, J = 14.2, 8.6, 7.8 Hz), 1.70 (3H, q, 1.3 Hz), 1.61 (3H, d, J = 0.8 Hz), 1.59 
(1H, dddq, J = 8.4, 6.1, 4.8, 6.8 Hz), 0.86 (3H, d, J = 6.8 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) 
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δ 174.1, 133.0, 123.0, 72.0, 52.0, 39.6, 38.5, 31.2, 25.9, 17.9, 15.3; [α]20D = −20.5 (1.29, 
CH2Cl2); IR (neat) 3472, 2964, 2925, 2881, 1739, 1438, 1405, 1377, 1339, 1288, 1260, 1196, 
1170, 1113, 1051, 1018, 990, 880, 846 cm-1; MS (EI) m/z (rel. intensity) 200 ([M+], 11), 182 
(55), 167 (9), 150 (14), 122 (40), 109 (62), 107 (56), 103 (24), 93 (25), 81 (22), 69 (84), 55 
(57), 41 (100), 29 (37); HR-MS (EI) (C11H20O3) calcd. 200.1412, found 200.1413; 
C11H20O3 (200.28) calcd. C 65.97, H 10.07; found C 66.11, H 9.98. 
 
(3S,4R)-3-Methoxymethoxy-4,7-dimethyl-oct-6-enoic acid methyl ester (15). N,N-
Dimethylaminopyridine (35 mg, 0.29 mmol), diisopropylethylamine (1.52 mL, 8.7 mmol) and 
MOMCl (0.66 mL, 8.7 mmol) are added to a solution of compound 14 (580 mg, 2.9 mmol) in 
CH2Cl2 (60 mL). Stirring at ambient temperature is continued for 40 h. After dilution with 
ethyl acetate (200 mL) the organic phase is washed with brine (2 x 50 mL), dried over 
Na2SO4, evaporated and the crude product is purified by flash chromatography 
(hexanes/ethyl acetate, 10:1) affording product 15 as a colourless oil (637 mg, 90 %). 1H-
NMR (CD2Cl2, 300 MHz) δ 5.15 - 5.08 (1H, m), 4.61 (2H, s), 3.95 - 3.87 (1H, m), 3.65 (3H, 
s), 3.30 (3H, s), 2.44 (1H, d, J = 7.4 Hz), 2.43 (1H, d, 4.9 Hz), 2.08 - 1.95 (1H, m), 1.88 - 1.75 
(2H, m), 1.70 (3H, s), 1.60 (3H, s), 0.86 (3H, d, J = 6.5 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) 
δ 172.7, 133.0, 123.0, 96.7, 78.8, 55.8, 51.8, 37.7, 36.7, 31.5, 25.9, 17.9, 14.5; [α]20D = −15.6 
(1.90, CH2Cl2); IR (KBr) 2962, 2932, 2889, 2824, 1742, 1673, 1437, 1378, 1343, 1290, 1272, 
1214, 1194, 1173, 1150, 1100, 1043, 976, 919, 857, 821 cm-1; MS (EI) m/z (rel. intensity) 
244 ([M+], < 1), 212 (12), 194 (3), 182 (18), 167 (3), 155 (4), 139 (6), 121 (19), 103 (23), 81 
(9), 69 (33), 55 (24), 45 (100), 41 (25), 29 (9); HR-MS (CI) (C13H24O3 + H) calcd. 245.1753, 
found 245.1754; C13H24O4 (244.33) calcd. C 63.91, H 9.90; found C 64.06, H 10.05. 
 
(5S,6R)-5-Methoxymethoxy-6,9-dimethyl-3-oxo-dec-8-enoic acid tert-butyl ester (16). A 
solution of tert-butyl acetate (2.11 mL, 15.66 mmol) in THF (10 mL) is slowly added to a 
solution of LiHMDS (2.62 g, 15.66 mmol) in THF (100 mL) at −45 °C. The temperature is 
raised to −30 °C over a period of 90 minutes. A solution of compound 15 (636 mg, 2.60 
mmol) in THF (20 mL) is then added at −40 °C. Stirring is continued for 3h while the 
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temperature is raised again to −30 °C. Quenching with aq. sat. NH4Cl, extraction with Et2O, 
drying of the combined organic phases over Na2SO4, evaporation of the solvent and flash 
chromatography (hexanes/ethylacetate 10:1) affords product 16 as a colourless oil (839 mg, 
98 %). According to NMR, the product consists of a 13:1 mixture of the keto-enol tautomers.  
NMR-Data for major keto-form: 1H-NMR (CD2Cl2, 300 MHz) δ 5.16 - 5.08 (1H, m), 4.58 
(2H, s), 4.01 - 3.94 (1H, m), 3.37 (2H, s), 3.29 (3H, s), 2.73 (1H, dd, J = 16.2, 8.7 Hz), 2.52 
(1H, dd, J = 16.2, 3.2 Hz), 2.04 - 1.92 (1H, m), 1.87 - 1.76 (2H, m), 1.70 (3H, s), 1.59 (3H, s), 
1.45 (9H, s), 0.86 (3H, d, J = 6.4 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) δ 202.5, 166.7, 133.0, 
122.9, 96.7, 81.9, 77.7, 55.9, 51.9, 44.4, 37.6, 31.7, 28.1, 25.9, 18.0, 14.5; [α]20D = −18.1 
(1.29, CH2Cl2); IR (neat) 2975, 2931, 2824, 1738, 1717, 1643, 1456, 1408, 1393, 1369, 1319, 
1286, 1253, 1212, 1150, 1099, 1040, 944, 919, 840 cm-1; MS (EI) m/z (rel. intensity) 328 
([M+], < 1), 296 (2), 266 (1), 240 (25), 223 (5), 210 (15), 181 (9), 139 (15), 123 (14), 109 
(22), 97 (15), 81 (10), 69 (32), 57 (72), 45 (100), 41 (31), 29 (13); HR-MS (CI) (C18H32O5 + 
H) calcd. 329.2328, found 329.2328; C18H32O5 (328.45) calcd. C 65.82, H 9.82; found C 
65.70, H 9.74. 
 
(3R,5S,6R)-3-Hydroxy-5-methoxymethoxy-6,9-dimethyl-dec-8-enoic acid tert-butyl ester 
(17). A stainless steel autoclave (50 mL) is charged with a solution of keto ester 16 (827 mg, 
2.52 mmol) in MeOH (20 mL). After addition of [(R)-BINAP·RuCl2]2·NEt3 (3.1 mM in THF, 
10 mL, 0.031 mmol, 1.2 mol%) the autoclave is pressurized with H2 (80 atm) and the reaction 
mixture is stirred for 6.5 h at 25 °C. After the autoclave has been ventured, the solvent is 
removed in vacuo and the residue is purified by flash chromatography (hexanes/ethyl acetate, 
4:1) affording product 17 (777 mg, 93 %) as a colourless oil. 1H-NMR (CD2Cl2, 300 MHz) δ 
5.16 - 5.08 (1H, m), 4.67 (1H, d, J = 6.8 Hz), 4.60 (1H, d, J = 6.8 Hz), 4.15 - 4.06 (1H, m), 
3.67 - 3.60 (1H, m), 3.55 - 3.30 (1H, br s), 3.36 (3H, s), 2.41 (1H, dd, J = 15.7, 4.6 Hz), 2.32 
(1H, dd, J = 15.7, 7.9 Hz), 1.98 - 1.78 (3H, m), 1.70 (3H, s), 1.69 - 1.41 (2H, m), 1.60 (3H, s), 
1.44 (9H, s), 0.86 (3H, d, J = 6.4 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) δ 172.0, 132.8, 123.2, 
96.0, 81.0, 80.5, 67.8, 56.1, 43.2, 36.8, 36.5, 31.7, 28.2, 25.9, 18.0, 14.1; [α]20D = −41.5 
(1.20, CH2Cl2); IR (KBr) 3468, 2971, 2932, 1729, 1632, 1455, 1392, 1368, 1340, 1302, 1258, 
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1214, 1151, 1097, 1034, 951, 917, 844, 774 cm-1; MS (EI) m/z (rel. intensity) 330 ([M+], <1), 
242 (29), 224 (14), 212 (42), 183 (20), 145 (38), 123 (13), 115 (61), 95 (21), 81 (14), 69 (44), 
57 (63), 45 (100); HR-MS (CI) (C18H34O5 + H) calcd. 331.2484, found 331.2485; C18H34O5 
(330.47) calcd. C 65.42, H 10.37; found C 65.36, H 10.45. 
 
(3S,5S,6R)-5-Methoxymethoxy-6,9-dimethyl-dec-8-ene-1,3-diol (18). LiAlH4 (114 mg, 3 
mmol) is added to a solution of compound 17 (330 mg, 1 mmol) in Et2O (50 mL) at 0 °C. 
Careful addition of aq. sat. NH4Cl (20 mL) after 6 h, extraction with Et2O (3 x 50 mL), 
drying of the combined organic phases over Na2SO4, evaporation of the solvent and flash 
chromatography of the residue (hexanes/ethyl acetate, 1:1   DIIRUGV GLRO 18 as a 
colourless oil (255 mg, 98 %). 1H-NMR (CD2Cl2, 300 MHz) δ 5.15 - 5.07 (1H, m), 4.67 (1H, 
d, J = 6.6 Hz), 4.62 (1H, d, J = 6.6 Hz), 4.05 - 3.95 (1H, m), 3.81 - 3.65 (4H, m), 3.37 (3H, s), 
3.20 - 2.85 (1H, br s), 1.98 - 1.78 (3H, m), 1.74 - 1.61 (3H, m), 1.70 (3H, s), 1.59 (3H, s), 1.55 
- 1.46 (1H, m), 0.86 (3H, d, J = 6.0 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) δ 132.9, 123.1, 95.9, 
81.9, 72.2, 61.6, 56.2, 39.3, 36.8, 36.7, 31.9, 25.8, 17.9, 13.8; [α]20D = −51.1 (1.19, CH2Cl2); 
IR (neat) 3386, 2961, 2931, 2888, 1658, 1442, 1377, 1212, 1151, 1097, 1037, 969, 918, 864, 
822, 724 cm-1; MS (EI) m/z (rel. intensity) 260 ([M+], < 1), 228 (5), 210 (2), 198 (8), 183 
(10), 165 (2), 141 (7), 124 (8), 110 (14), 101 (43), 95 (17), 83 (17), 69 (34), 55 (29), 45 (100), 
41 (25), 29 (12); C14H28O4 (260.37) calcd. C 64.58, H 10.84, found C 64.46, H 10.95. 
 
(3S,5S,6R)-1-(4-Methoxy-benzyloxy)-5-methoxymethoxy-6,9-dimethyl-dec-8-en-3-ol (19). 
A solution of diol 18 (294 mg, 1.13 mmol) in DMF (10 mL) is added to a suspension of NaH 
(109 mg, 4.52 mmol) in DMF (15 mL). The mixture is stirred for 75 minutes before PMBCl 
(153 µL, 1.13 mL) is added via syringe. After stirring for another 90 minutes, the reaction is 
quenched by addition of diethylamine (5 drops). The reaction mixture is diluted with ethyl 
acetate (50 ml) and the organic phase is washed with brine (3 x 20 mL). Drying over Na2SO4, 
evaporation of the solvent and flash chromatography (hexanes/ethyl acetate, 2:1) affords 
product 19 as a colourless oil (345 mg, 85 %). 1H-NMR (CD2Cl2, 300 MHz) δ 7.25 (2H, d, J 
= 8.6 Hz), 6.86 (2H, d, J = 8.6 Hz), 5.16 - 5.07 (1H, m), 4.67 (1H, d, J = 6.7 Hz), 4.60 (1H, d, 
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J = 6.6 Hz), 4.42 (2H, s), 3.94 - 3.84 (1H, m), 3.79 (3H, s), 3.69 - 3.53 (3H, m), 3.50 - 3.25 
(1H, br s), 3.36 (3H, s), 1.97 - 1.49 (7H, m), 1.71 (3H, s), 1.59 (3H, s), 0.86 (3H, d, J = 6.3 
Hz); 13C-NMR (CD2Cl2, 75.5 MHz) δ 159.6, 132.7, 131.0, 129.6, 123.3, 114.0, 95.9, 81.1, 
73.1, 69.7, 68.3, 56.1, 55.5, 37.5, 37.1, 36.8, 31.8, 25.9, 17.9, 14.1; [α]20D = −26.0 (1.32, 
CH2Cl2); IR (KBr) 3463, 2930, 1613, 1586, 1514, 1463, 1442, 1375, 1302, 1248, 1210, 1173, 
1152, 1096, 1036, 969, 917, 821, 773, 756, 707, 637, 571, 518 cm-1; MS (EI) m/z (rel. 
intensity) 380 ([M+], < 1), 348 (1), 247 (1), 227 (2), 197 (4), 176 (2), 151 (1), 137 (13), 121 
(100), 101 (7), 69 (7), 55 (4), 45 (15); C22H36O5 (380.52) calcd. C 69.44, H 9.54; found C 
69.46, H 9.48. 
 
2-Allyl-6-hydroxy-benzoic acid (1R,3S,4R)-1-[2-(4-methoxy-benzyloxy)-ethyl]-3-
methoxymethoxy-4,7-dimethyl-oct-6-enyl ester (23a).  A solution of alcohol 19 (152 mg, 
0.4 mmol) and PPh3 (210 mg, 0.8 mmol) in Et2O (15 mL) is added dropwise at ambient 
temperature to a solution of the carboxylic acid 7 (142 mg, 0.8 mmol) and DEAD (126 µL, 
0.8 mmol) in Et2O (25 mL). After stirring for 20h, the mixture is concentrated to a volume of 
ca. 5 mL and precipitated triphenylphosphine oxide is removed by filtration. Drying over 
Na2SO4, evaporation and flash chromatography (hexanes/ethyl acetate, 20:1) affords ester 
23a as a colourless oil (190 mg, 88 %). 1H-NMR (CD2Cl2, 300 MHz) δ 11.09 (1H, s), 7.31 
(1H, dd, J = 8.0, 7.5 Hz), 7.21 (2H, d, J = 8.6 Hz), 6.84 (1H, d, J = 8.0 Hz), 6.81 (2H, d, J = 
8.6 Hz), 6.73 (1H, d, J = 7.5 Hz), 5.98 (1H, ddt, J = 17.1, 10.2, 6.1 Hz), 5.62 - 5.53 (1H, m), 
5.12 - 5.05 (1H, m), 5.01 (1H, dd, J = 10.2, 1.6 Hz), 4.93 (1H, dd, J = 17.1, 1.6 Hz), 4.64 (1H, 
d, J = 6.8 Hz), 4.55 (1H, d, J = 6.8 Hz), 4.38 (2H, s), 3.76 (3H, s), 3.69 (1H, d, J = 6.0 Hz), 
3.64 (1H, d, J = 6.0 Hz), 3.60 - 3.49 (3H, m), 3.33 (3H, s), 2.12 - 1.48 (7H, m), 1.63 (3H, s), 
1.56 (3H, s), 0.87 (3H, d, J = 6.4 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) δ 171.1, 162.7, 159.6, 
143.0, 138.3, 134.3, 132.8, 130.8, 129.6, 123.1, 122.7, 116.3, 115.5, 113.9, 113.3, 96.9, 78.5, 
73.0, 72.4, 66.8, 55.5, 54.5, 40.3, 37.4, 35.5, 35.2, 31.8, 25.7, 17.9, 13.8; [α]20D = −15.1 
(1.02, CH2Cl2); IR (neat) 3374, 3059, 2960, 2928, 1723, 1656, 1608, 1578, 1514, 1450, 1374, 
1302, 1249, 1222, 1165, 1098, 1039, 999, 917, 818, 767, 712, 573 cm-1; MS (EI) m/z (rel. 
intensity) 540 ([M+], < 1), 508 (2), 387 (1), 330 (1), 298 (2), 211 (2), 179 (3), 161 (7), 139 
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(1), 121 (100), 109 (1), 69 (4), 45 (10); C32H44O7 (540.70) calcd. C 71.08, H 8.20; found C 
71.15, H 8.12. 
 
2-Allyl-6-methoxy-benzoic acid (1R,3S,4R)-1-[2-(4-methoxy-benzyloxy)-ethyl]-3-
methoxymethoxy-4,7-dimethyl-oct-6-enyl ester (23b). A solution of diene 23a (54.0 mg, 
0.1 mmol) and trimethylsilyl diazomethane (2 M in hexane, 250 µL, 0.5 mmol) in THF (4 
mL) and MeOH (2 mL) is stirred at ambient temperature. Additional trimethylsilyl 
diazomethane (2 M in hexane, 250 µL, 0.5 mmol) is added after 38 h, and stirring is 
continued for another 8 h. The reaction is quenched by addition of a few drops of acetic acid. 
Evaporation of the solvent and flash chromatography (hexanes/ethyl acetate, 10:1  
affords compound 23b as a colourless oil (29.8 mg, 54 %). 1H-NMR (CD2Cl2, 300 MHz) δ 
7.33 - 7.24 (3H, m), 6.89 - 6.78 (4H, m), 6.02 - 5.85 (1H, m), 5.45 - 5.34 (1H, m), 5.13 - 5.01 
(3H, m), 4.69 (2H, s), 4.46 (1H, d, J = 11.4 Hz), 4.42 (1H, d, J = 11.4 Hz), 3.80 (3H, s), 3.79 
(3H, s), 3.69 - 3.55 (3H, m), 3.37 (3H, s), 3.34 (2H, d, J = 6.5 Hz), 2.12 - 1.67 (7H, m), 1.60 
(3H, s), 1.52 (3H, s), 0.87 (3H, d, J = 6.2 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) δ 168.0, 159.6, 
156.6, 138.5, 137.0, 132.5, 131.2, 130.5, 129.6, 124.7, 123.3, 121.9, 116.4, 114.0, 109.2, 97.1, 
78.5, 72.9, 71.1, 66.8, 55.9, 55.8, 55.6, 37.7, 37.5, 35.6, 35.4, 32.0, 25.8, 17.8, 14.0. 
 
 2-Allyl-6-methoxymethoxy-benzoic acid (1R,3S,4R)-1-[2-(4-methoxy-benzyloxy)-ethyl]-
3-methoxymethoxy-4,7-dimethyl-oct-6-enyl ester (23c). Diisopropylethylamine (261 µL, 
1.5 mmol) and MOMCl (76 µL, 1 mmol) are added to a solution of compound 23a (54.0 mg, 
0.1 mmol) in CH2Cl2 (5 mL) and the mixture is stirred for 18 h. After dilution with ethyl 
acetate (20 mL), the organic phase is washed with brine (2 x 10 mL). Drying over Na2SO4, 
evaporation of the solvent and flash chromatography (hexanes/ethyl acetate, 10:1) affords 
product 23c as a colourless oil (49.2 mg, 84 %). 1H-NMR (CD2Cl2, 300 MHz) δ 7.33 - 7.24 
(3H, m), 7.02 (1H, d, J = 8.4 Hz), 6.93 - 6.84 (3H, m), 6.03 - 5.86 (1H, m), 5.47 - 5.36 (1H, 
m), 5.18 (1H, d, J =6.8 Hz), 5.12 (1H, d, J =6.8 Hz), 5.10 - 5.02 (3H, m), 4.69 (2H, s), 4.46 
(1H, d, J = 11.4 Hz), 4.42 (1H, d, J = 11.4 Hz), 3.79 (3H, s), 3.68 - 3.55 (3H, m), 3.43 (3H, s), 
3.38 (3H, s), 3.36 (2H, d, J = 6.5 Hz), 2.12 - 1.68 (7H, m), 1.59 (3H, s), 1.51 (3H, s), 0.87 
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(3H, d, J = 6.2 Hz); 13C-NMR (CD2Cl2, 75.5 MHz) δ 167.8, 159.6, 154.2, 138.6, 136.9, 
132.6, 131.1, 130.4, 129.5, 125.5, 123.3, 122.9, 116.5, 114.0, 112.6, 97.0, 94.9, 78.4, 73.0, 
71.2, 66.8, 56.3, 55.9, 55.5, 37.7, 37.5, 35.6, 35.3, 32.0, 25.8, 17.8, 14.0; IR (neat) 2959, 
2931, 1726, 1639, 1612, 1585, 1513, 1465, 1442, 1376, 1301, 1249, 1208, 1155, 1097, 1036, 
947, 919, 821, 755, 580 cm-1; MS (EI) m/z (rel. intensity) 584 ([M+], < 1), 539 (3), 507 (2), 
416 (4), 403 (3), 371 (3), 305 (1), 223 (2), 205 (10), 161 (7), 121 (100), 69 (3), 45 (15). 
 
2-Allyl-6-(tert-butyl-dimethyl-silanyloxy)-benzoic acid (1R,3S,4R)-1-[2-(4-methoxy-
benzyloxy)-ethyl]-3-methoxymethoxy-4,7-dimethyl-oct-6-enyl ester (23d). A solution of 
diene 23a (103 mg, 0.19 mmol), imidazole (129 mg, 1.90 mmol) and TBSCl (229 mg, 1.52 
mmol) in DMF (10 mL) is stirred for 24 h at ambient temperature. The reaction mixture is 
diluted with ethyl acetate (50 mL) and the organic phase is washed with brine (3 x 20 mL). 
Drying over Na2SO4, evaporation of the solvent and flash chromatography (hexanes/ethyl 
acetate, 15:1) affords product 23d as a colourless oil (111 mg, 89 %). 1H-NMR (CD2Cl2, 300 
MHz) δ 7.26 (2H, d, J =8.6 Hz), 7.18 (1H, dd, J = 8.2, 7.9 Hz), 6.86 (2H, d, J = 8.6 Hz), 6.82 
(1H, d, J = 7.9 Hz), 6.74 (1H, d, J = 8.2 Hz), 6.02 - 5.87 (1H, m), 5.27 - 5.18 (1H, m), 5.11 - 
5.01 (3H, m), 4.65 (1H, d, J = 6.8 Hz), 4.60 (1H, d, J = 6.8 Hz), 4.45 (1H, d, J = 11.4 Hz), 
4.39 (1H, d, J = 11.4 Hz), 3.79 (3H, s), 3.65 - 3.52 (3H, m), 3.40 - 3.32 (2H, m), 3.35 (3H, s), 
2.20 - 2.09 (1H, m), 2.05 - 1.92 (2H, m), 1.88 - 1.68 (4H, m), 1.61 (3H, s), 1.52 (3H, s), 0.98 
(9H, s), 0.86 (3H, d, J = 6.3 Hz), 0.25 (6H, s); 13C-NMR (CD2Cl2, 75.5 MHz) δ 168.0, 159.5, 
152.9, 138.8, 137.1, 132.7, 131.2, 130.1, 129.5, 127.3, 123.3, 122.1, 117.3, 116.4, 114.0, 96.6, 
78.9, 72.8, 72.2, 67.0, 55.9, 55.5, 37.8, 37.5, 35.3, 35.2, 31.6, 26.0, 25.8, 18.8, 17.9, 14.2, - 
3.9; [α]20D = −12.4 (1.02, CH2Cl2); IR (neat) 3077, 2955, 2930, 2887, 2858, 1728, 1639, 
1613, 1594, 1584, 1514, 1464, 1408, 1376, 1362, 1282, 1250, 1172, 1155, 1099, 1062, 1037, 
917, 838, 785, 743, 716, 668, 579 cm-1; MS (EI) m/z (rel. intensity) 654 ([M+], < 1), 597 (1), 
486 (2), 331 (1), 301 (2), 275 (9), 235 (8), 203 (3), 137 (1), 121 (100), 69 (5), 45 (13); 




methyl-7,8,9,10,11,14-hexahydro-6-oxa-benzocyclododecen-5-one (24a). Carbene 21 (2.1 
mg, 0.0025 mmol, 5 mol%) is added to a solution of diene 23a (27.0 mg, 0.05 mmol) in 
toluene (50 mL) at 80 °C. Additional catalyst 21 (2.1 mg, 0.0025 mmol, 5 mol%) is added 
after 2 h. The reaction is stopped after 20 h upon addition of ethoxy-ethene (1 mL). 
Evaporation of the solvent and flash chromatography (hexanes/ethyl acetate, 10:1) affords 
(Z)-24a as a colourless oil (16.6 mg, 69 %). 1H-NMR (C6D6, 300 MHz) δ 11.69 (1H, s), 7.23 
- 7.17 (2H, m), 6.98 - 6.95 (2H, m), 6.83 - 6.76 (2H, m), 6.48 - 6.43 (1H, m), 5.75 - 5.65 (1H, 
m), 5.18 - 5.03 (2H, m), 4.55 (1H, d, J = 6.9 Hz), 4.49 (1H, d, J = 6.9 Hz), 4.48 - 4.40 (1H, 
m), 4.25 (1H, d, J = 11.5 Hz), 4.20 (1H, d, J = 11.5 Hz), 3.74 - 3.68 (1H, m), 3.34 - 3.28 (2H, 
m), 3.30 (3H, s), 3.23 (3H, s), 2.90 - 2.82 (1H, m), 2.07 - 1.62 (7H, m), 0.88 (3H, d, J = 6.6 
Hz); 13C-NMR (C6D6, 75.5 MHz) δ 171.7, 163.8, 159.7, 144.7, 134.6, 131.5, 130.9, 129.5, 
127.9, 123.0, 116.8, 114.0, 113.0, 95.9, 76.5, 74.1, 72.9, 66.4, 55.3, 54.7, 36.0, 35.5, 35.2, 
35.0, 32.2, 13.8; IR (neat) 2956, 2932, 1657, 1606, 1576, 1513, 1449, 1361, 1295, 1247, 
1217, 1165, 1098, 1038, 992, 916, 816, 770, 714, 669, 662 cm-1; MS (EI) m/z (rel. intensity) 
484 ([M+], 1), 452 (5), 439 (4), 303 (3), 286 (2), 176 (1), 150 (1), 121 (100), 77 (2), 45 (9). 
 
(7R,9S,10R)-4-Methoxy-7-[2-(4-methoxy-benzyloxy)-ethyl]-9-methoxymethoxy-10-
methyl-7,8,9,10,11,14-hexahydro-6-oxa-benzocyclododecen-5-one (24b). Carbene 21 (2.3 
mg, 0.0027 mmol, 5 mol%) is added to a solution of diene 23b (29.8 mg, 0.054 mmol) in 
toluene (50 mL) at 80 °C. The reaction is stopped after 90 minutes upon addition of ethoxy-
ethene (1 mL). Evaporation of the solvent and flash chromatography (hexanes/ethyl acetate, 
4:1) affords product 24b as a colourless oil (25.0 mg, 93 %). The macrocycle is formed as a 
mixture of E/Z-isomers (66/34). (E)-24c: 1H-NMR (C6D6, 300 MHz) δ 7.30 (2H, d, J = 8.6 
Hz), 7.03 - 6.91 (1H, m), 6.82 (2H, d, J = 8.6 Hz), 6.55 (1H, d, J = 7.5 Hz), 6.34 (1H, d, J = 
7.6 Hz), 5.91 - 5.80 (1H, m), 5.48 - 5.21 (2H, m), 5.03 (1H, d, J = 6.7 Hz), 4.81 (1H, d, J = 6.7 
Hz), 4.48 - 4.44 (1H, m), 4.43 (2H, s), 3. 89 - 3.78 (1H, m), 3.75 - 3.63 (2H, m) 3.35 (3H, s), 
3.29 (3H, s), 3.25 - 3.15 (1H, m), 3.17 (3H, s), 2.20 - 1.86 (4H, m), 1.80 - 1.52 (3H, m), 0.87 
(3H, d, J = 6.6 Hz); 13C-NMR (C6D6, 75.5 MHz) δ 168.0, 159.6, 157.1, 139.6, 131.6, 131.5, 
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129.7, 129.2, 129.0, 128.9, 123.0, 114.1, 109.6, 97.1, 79.6, 72.8, 72.1, 66.8, 55.4, 55.0, 54.7, 
38.1, 38.0, 37.2, 36.4, 34.4, 13.6; (Z)-24c: 1H-NMR (C6D6, 300 MHz) δ 7.31 (2H, d, J = 8.6 
Hz), 7.03 - 6.91 (1H, m), 6.82 (2H, d, J = 8.6 Hz), 6.63 (1H, d, J = 7.5 Hz), 6.38 (1H, d, J = 
7.6 Hz), 5.91 - 5.80 (1H, m), 5.48 - 5.21 (2H, m), 4.88 (1H, d, J = 6.7 Hz), 4.73 (1H, d, J = 6.7 
Hz), 4.29 (2H, s), 4.13 - 4.02 (2H, m), 3.56 - 3.50 (2H, m), 3.30 (3H, s), 3.29 (3H, s), 3.25 
(3H, s), 2.96 - 2.87 (1H, m), 2.20 - 1.86 (4H, m), 1.80 - 1.52 (3H, m), 0.89 (3H, d, J = 6.6 
Hz); 13C-NMR (C6D6, 75.5 MHz) δ 166.5, 160.3, 157.6, 140.3, 131.3, 130.4, 129.6, 129.5, 
128.8, 125.9, 122.9, 114.0, 110.0, 97.2, 78.0, 73.0, 72.1, 66.7, 55.6, 55.3, 54.7, 36.7, 36.5, 
36.1, 32.9, 32.2, 13.6; IR (neat) 3064, 2956, 2929, 2839, 1725, 1612, 1597, 1584, 1513, 1468, 
1439, 1380, 1362, 1301, 1273, 1250, 1173, 1154, 1098, 1069, 1039, 972, 951, 916, 820, 758, 
728, 698, 637, 503 cm-1; MS (EI) m/z (rel. intensity) 498 ([M+], < 1), 466 (4), 453 (7), 436 
(2), 300 (13), 245 (5), 215 (4), 176 (12), 135 (5), 121 (100), 95 (3), 77 (3), 55 (3), 45 (16). 
 
(7R,9S,10R)-7-[2-(4-Methoxy-benzyloxy)-ethyl]-4,9-bis-methoxymethoxy-10-methyl-
7,8,9,10,11,14-hexahydro-6-oxa-benzocyclododecen-5-one (24c). Carbene 21 (2.9 mg, 
0.0035 mmol, 5 mol%) is added to a solution of diene 23c (41.0 mg, 0.07 mmol) in toluene 
(50 mL) at 80 °C. Additional catalyst 21 (2.9 mg, 0.0035 mmol, 5 mol%) is introduced after 1 
h. The reaction is stopped after 2 h upon addition of ethoxy-ethene (1 mL). Evaporation of the 
solvent and flash chromatography (hexanes/ethyl acetate, 4:1) affords product 24c as a 
colourless oil (33.8 mg, 91 %). The macrocycle is formed as a mixture of E/Z-isomers 
(68/32). (E)-24c: 1H-NMR (C6D6, 300 MHz) δ 7.34 - 7.26 (2H, m), 7.01 - 6.87 (2H, m), 6.84 
- 6.77 (2H, m), 6.58 - 6.53 (1H, m), 5.92 - 5.82 (1H, m), 5.48 - 5.21 (2H, m), 5.02 (1H, d, J = 
6.7 Hz), 4.84 - 4.72 (3H, m), 4.47 - 4.43 (1H, m), 4.40 (2H, s), 3.92 - 3.51 (4H, m), 3.35 (3H, 
s), 3.29 (3H, s), 3.11 (3H, s), 2.18 - 1.57 (7H, m), 0.87 (3H, d, J = 6.9 Hz); 13C-NMR (C6D6, 
75.5 MHz) δ 167.9, 159.7, 154.9, 139.6, 131.5, 131.3, 129.8, 129.4, 129.2, 126.5, 123.9, 
114.1, 113.2, 97.1, 94.5, 79.7, 72.8, 72.2, 66.7, 55.7, 55.4, 54.8, 38.1, 38.0, 36.8, 36.2, 34.4, 
13.6; (Z)-24c: 1H-NMR (C6D6, 300 MHz) δ 7.34 - 7.26 (2H, m), 7.01 - 6.87 (2H, m), 6.84 - 
6.77 (2H, m), 6.66 - 6.62 (1H, m), 5.92 - 5.82 (1H, m), 5.48 - 5.21 (2H, m), 4.92 (1H, d, J = 
6.7 Hz), 4.84 - 4.72 (3H, m), 4.29 (2H, s), 4.11 - 3.98 (2H, m), 3.92 - 3.51 (2H, m), 3.30 (3H, 
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s), 3.29 (3H, s), 3.17 (3H, s), 2.94 - 2.85 (1H, m), 2.18 - 1.57 (7H, m), 0.88 (3H, d, J = 6.9 
Hz); 13C-NMR (C6D6, 75.5 MHz) δ 166.5, 159.7, 155.3, 140.3, 131.5, 131.4, 130.5, 129.6, 
129.0, 126.0, 124.0, 114.0, 113.9, 97.3, 94.9, 78.0, 73.0, 72.0, 66.7, 55.9, 55.3, 54.8, 37.1, 
36.8, 36.2, 32.9, 32.2, 13.6; IR (KBr) 2956, 1724, 1612, 1599, 1583, 1513, 1462, 1442, 1423, 
1402, 1375, 1359, 1302, 1271, 1249, 1208, 1171, 1154, 1116, 1095, 1066, 1039, 971, 937, 
920, 808, 769, 729, 697, 638, 596, 572, 515 cm-1; MS (EI) m/z (rel. intensity) 528 ([M+], < 
1), 496 (2), 483 (7), 436 (2), 347 (5), 330 (2), 315 (1), 285 (1), 176 (2), 152 (4), 137 (1), 121 




(24d). Carbene 21 (5.9 mg, 0.007 mmol, 5 mol%) is added to a solution of diene 23d (91.6 
mg, 0.14 mmol) in toluene (70 ml) at 80 °C. The reaction is stopped after 1 h upon addition of 
ethoxy-ethene (1 mL). Evaporation of the solvent and flash chromatography (hexanes/ethyl 
acetate, 15:1) affords product 24d as a colourless oil (76.4 mg, 91 %). The macrocycle is 
formed as a mixture of E/Z-isomers (40/60). (E)-24d: 1H-NMR (C6D6, 600 MHz) δ 7.27 (2H, 
d, J = 9.0 Hz), 6.91 (1H, dd, J = 8.2, 7.6 Hz), 6.84 - 6.82 (2H, m), 6.70 (1H, d, J = 8.2 Hz), 
6.56 (1H, d, J = 7.6 Hz), 5.78 - 5.74 (1H, m), 5.40 - 5.36 (2H, m), 5.06 (1H, d, J = 6.7 Hz), 
4.81 (1H, d, J = 6.7 Hz), 4.40 - 4.37 (1H, m), 4.35 (2H, s), 3.76 - 3.70 (1H, m), 3.60 - 3.57 
(2H, m), 3.35 (3H, s), 3.31 (3H, s), 3.21 - 3.17 (1H, m), 2.31 - 2.24 (1H, m), 2.19 - 2.00 (3H, 
m), 1.73 - 1.69 (2H, m), 1.64 - 1.60 (1H, m), 1.00 (9H, s), 0.89 (3H, d, J = 6.8 Hz), 0.21 (3H, 
s), 0.10 (3H, s); 13C-NMR (C6D6, 151 MHz) δ 168.2, 159.7, 153.4, 139.2, 131.4, 131.3, 
129.4, 129.2, 129.1, 129.0, 123.6, 118.4, 114.0, 97.4, 79.5, 72.8, 72.5, 66.7, 55.4, 54.7, 38.3, 
38.1, 36.6, 35.4, 34.5, 26.1, 18.6, 13.8, - 3.9, - 4.2; (Z)-24d: 1H-NMR (C6D6, 600 MHz) δ 
7.26 (2H, d, J = 9.0 Hz), 6.97 (1H, dd, J = 8.2, 7.6 Hz), 6.82 - 6.80 (2H, m), 6.73 (1H, d, J = 
8.2 Hz), 6.62 (1H, d, J = 7.6 Hz), 5.88 - 5.84 (1H, m), 5.35 - 5.30 (1H, m), 5.26 - 5.20 (1H, 
m), 4.97 (1H, d, J = 6.7 Hz), 4.76 (1H, d, J = 6.7 Hz), 4.39 (1H, d, J = 11.5 Hz), 4.32 (1H, d, J 
= 11.5 Hz), 4.08 - 4.02 (2H, m), 3.55 - 3.52 (2H, m), 3.31 (3H, s), 3.30 (3H, s), 2.91 - 2.87 
(1H, m), 2.12 - 1.90 (4H, m), 1.81 - 1.75 (1H, m), 1.74 - 1.70 (1H, m), 1.69 - 1.62 (1H, m), 
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1.04 (9H, s), 0.90 (3H, d, J = 6.8 Hz), 0.25 (3H, s), 0.17 (3H, s); 13C-NMR (C6D6, 151 MHz) 
δ 166.5, 159.7, 154.1, 141.0, 131.3, 130.4, 129.8, 129.3, 128.9, 127.2, 123.4, 118.0, 114.0, 
97.6, 77.9, 72.8, 71.4, 67.0, 55.3, 54.7, 37.0, 36.7, 36.5, 33.1, 32.3, 26.0, 18.5, 13.7, - 4.0, - 
4.3; IR (KBr) 3064, 2956, 2931, 2897, 2857, 1727, 1613, 1593, 1582, 1514, 1463, 1382, 
1362, 1282, 1251, 1172, 1155, 1100, 1065, 1040, 972, 914, 860, 839, 784, 733, 696, 670, 508 
cm-1; MS (EI) m/z (rel. intensity) 598 ([M+], < 1), 553 (1), 541 (6), 341 (4), 262 (4), 207 (5), 
121 (100), 45 (16). 
